However, the result showed a positive correlation (odds ratio: 3.24, confidence interval: 1.77-5.96) between the AR and DDB2 in human prostate cancer tissues (Supplementary Table 1A); it contradicted in vitro conclusion of DDB2-degrading AR. This evidence concerns the gene AR and prostate cancer.